Patents by Inventor Vincent Van Rixel

Vincent Van Rixel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Photoactivatable cancer prodrug
    Patent number: 10781226
    Abstract: Described herein is photocaging methodology using ruthenium (II) complexes with 7-deazahypoxanthine-based anticancer agents. Specifically, 7-deazahypoxanthines are converted into photoactivatable chemotherapeutic agents for the controlled release of these toxic agents selectively into tumor tissue upon irradiation with light.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: September 22, 2020
    Assignees: Texas State University, Leiden University
    Inventors: Alexander Kornienko, Tania Betan-Court, Sylvestre Bonnet, Vincent Van Rixel
  • PHOTOACTIVATABLE CANCER PRODRUG
    Publication number: 20200239503
    Abstract: Described herein is photocaging methodology using ruthenium (II) complexes with 7-deazahypoxanthine-based anticancer agents. Specifically, 7-deazahypoxanthines are converted into photoactivatable chemotherapeutic agents for the controlled release of these toxic agents selectively into tumor tissue upon irradiation with light.
    Type: Application
    Filed: October 19, 2017
    Publication date: July 30, 2020
    Inventors: Alexander Kornienko, Tania Betan-Court, Sylvestre Bonnet, Vincent Van Rixel